Article
JNK1 is not essential for TNF-mediated joint disease.
Arthritis research & therapy - 1 Jan 2005
Köller Marcus, Hayer Silvia, Redlich Kurt, Ricci Romeo, David Jean-Pierre, Steiner Günter, Smolen Josef S, Wagner Erwin F, Schett Georg
Abstract excerpt
Tumour necrosis factor (TNF) signalling molecules are considered as promising therapeutic targets of antirheumatic therapy. Among them, mitogen-activated protein kinases are thought to be of central importance. Herein, we investigate the role in vivo of TNF-alpha signalling through c-Jun N-terminal kinase (JNK)1 in destructive arthritis. Human TNF transgenic (hTNFtg) mice, which develop inflammatory arthritis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
